Chollet, Laurève; Iqbal, Salik Ur Rehman; Wittmer, Severin; Thalmann, Gregor; Madaffari, Antonio; Kozhuharov, Nikola; Galuszka, Oskar; Küffer, Thomas; Gräni, Christoph; Brugger, Nicolas; Servatius, Helge; Noti, Fabian; Haeberlin, Andreas; Roten, Laurent; Tanner, Hildegard; Reichlin, Tobias (2024). Impact of atrial fibrillation phenotype and left atrial volume on outcome after pulmonary vein isolation. Europace, 26(4) Oxford University Press 10.1093/europace/euae071
|
Text
euae071.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (427kB) | Preview |
AIMS
Pulmonary vein isolation (PVI) is increasingly performed in patients with atrial fibrillation (AF). Both AF phenotype and left atrial (LA) volume have been shown to influence ablation outcome. The inter-relationship of the two is incompletely understood. We aimed to investigate the impact of AF phenotype vs. LA volume on outcome after PVI.
METHODS AND RESULTS
In a retrospective analysis of a prospective registry of patients undergoing a first PVI, the association of AF phenotype and LA volume index (LAVI) was assessed as well as their impact on AF recurrence during follow-up. Overall, 476 patients were enrolled (median age 63 years, 29% females, 65.8% paroxysmal AF). Obesity, hypertension, chronic kidney disease, and heart failure were all significantly more frequent in persistent AF. After 1 year, single-procedure, freedom from arrhythmia recurrence was 61.5%. Patients with paroxysmal AF had better outcomes compared with patients with persistent AF (65.6 vs. 52.7%, P = 0.003), as had patients with no/mild vs. moderate/severe LA dilation (LAVI <42 mL/m2 67.1% vs. LAVI ≥42 mL/m2 53%, P < 0.001). The combination of both parameters refined prediction of 1-year recurrence (P < 0.001). After adjustment for additional clinical risk factors in multivariable Cox proportional hazard analysis, both AF phenotype and LAVI ≥42 mL/m2 contributed significantly towards the prediction of 1-year recurrence.
CONCLUSION
Atrial fibrillation phenotype and LA volume are independent predictors of outcome after PVI. Persistent AF with no/mild LA dilation has a similar risk of recurrence as paroxysmal AF with a moderate/severe LA dilation and should be given similar priority for ablation.